Alcon Operating Income 2019-2022 | ALC
Alcon annual/quarterly operating income history and growth rate from 2019 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Alcon operating income for the quarter ending September 30, 2022 was $0.205B, a 925% increase year-over-year.
- Alcon operating income for the twelve months ending September 30, 2022 was $833M, a 54.55% increase year-over-year.
- Alcon annual operating income for 2021 was $0.58B, a 220.33% decline from 2020.
- Alcon annual operating income for 2020 was $-0.482B, a 157.75% increase from 2019.
- Alcon annual operating income for 2019 was $-0.187B, a 24.6% decline from 2018.
Alcon Annual Operating Income
(Millions of US $) |
| 2021 |
$580 |
| 2020 |
$-482 |
| 2019 |
$-187 |
| 2018 |
$-248 |
Alcon Quarterly Operating Income
(Millions of US $) |
| 2022-09-30 |
$205 |
| 2022-06-30 |
$200 |
| 2022-03-31 |
$246 |
| 2021-12-31 |
$182 |
| 2021-09-30 |
$20 |
| 2021-06-30 |
$229 |
| 2021-03-31 |
$149 |
| 2020-12-31 |
$141 |
| 2020-09-30 |
$-129 |
| 2020-06-30 |
$-466 |
| 2020-03-31 |
$-28 |
| 2019-12-31 |
$-68 |
| 2019-09-30 |
$-18 |
| 2019-06-30 |
$-53 |
| 2019-03-31 |
$-48 |
| 2018-12-31 |
|
| 2018-09-30 |
$-284 |
| 2018-06-30 |
$38 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$37.369B |
$8.291B |
|
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
|
